ATE382099T1 - Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential - Google Patents
Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotentialInfo
- Publication number
- ATE382099T1 ATE382099T1 AT03075928T AT03075928T ATE382099T1 AT E382099 T1 ATE382099 T1 AT E382099T1 AT 03075928 T AT03075928 T AT 03075928T AT 03075928 T AT03075928 T AT 03075928T AT E382099 T1 ATE382099 T1 AT E382099T1
- Authority
- AT
- Austria
- Prior art keywords
- tslc1
- hpv
- invasive
- precursor lesions
- detection
- Prior art date
Links
- 230000003902 lesion Effects 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000002243 precursor Substances 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000009545 invasion Effects 0.000 title 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 2
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 abstract 2
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 abstract 2
- 201000005202 lung cancer Diseases 0.000 abstract 2
- 208000020816 lung neoplasm Diseases 0.000 abstract 2
- 239000003550 marker Substances 0.000 abstract 2
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 238000001574 biopsy Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000009595 pap smear Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000012360 testing method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03075928A EP1464709B1 (de) | 2003-03-31 | 2003-03-31 | Nachweis von invasivem Krebs induziert von HPV und dessen Vorläufer Läsionen mit Invasionspotential |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382099T1 true ATE382099T1 (de) | 2008-01-15 |
Family
ID=32842793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03075928T ATE382099T1 (de) | 2003-03-31 | 2003-03-31 | Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7501261B2 (de) |
| EP (1) | EP1464709B1 (de) |
| AT (1) | ATE382099T1 (de) |
| DE (1) | DE60318294T2 (de) |
| ES (1) | ES2298467T3 (de) |
| WO (1) | WO2004087962A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1688503A4 (de) * | 2003-10-20 | 2007-10-31 | Sysmex Corp | Verfahren zur behandlung von zellen |
| US7858323B2 (en) | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
| JP5131946B2 (ja) * | 2005-09-13 | 2013-01-30 | 国立大学法人 東京大学 | がんの診断、処置および／または予防、および／または浸潤・転移の抑制のための方法、システムおよび組成物ならびに関連するスクリーニング方法 |
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
| DK2069793T3 (en) | 2006-08-29 | 2017-04-24 | Oxford Biotherapeutics Ltd | IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER |
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
| US20100003704A1 (en) | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
| WO2009092017A1 (en) * | 2008-01-16 | 2009-07-23 | Medical College Of Georgia Research Institute, Inc. | Biomarkers for hpv-induced cancer |
| ES2425617T3 (es) * | 2008-04-14 | 2013-10-16 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Metilación de los promotores de MAL y de CADM1, marcador de diagnóstico molecular para cánceres cervicales invasivos inducidos por el VPH y sus lesiones precursoras de alto grado de malignidad |
| EA028336B1 (ru) * | 2009-03-05 | 2017-11-30 | МЕДАРЕКС Л.Л.Си. | Полностью человеческие антитела, специфические в отношении cadm1 |
| JP2012526286A (ja) | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス（ｈｐｖ）およびｈｐｖ関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧ｃｉｎ２の同定 |
| WO2011036173A1 (en) * | 2009-09-24 | 2011-03-31 | Oncomethylome Sciences S.A. | Detection and prognosis of cervical cancer |
| JP5819851B2 (ja) | 2010-01-08 | 2015-11-24 | オンコヘルス コーポレーション | Ｈｐｖ関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力ｈｐｖ免疫アッセイ |
| WO2011116209A2 (en) | 2010-03-17 | 2011-09-22 | The Regents Of The University Of Michigan | Using phage epitopes to profile the immune response |
| WO2011120015A2 (en) * | 2010-03-26 | 2011-09-29 | Armune Biosciences, Inc. | Method and system of particle-coupled phage epitope |
| WO2013130517A1 (en) * | 2012-02-27 | 2013-09-06 | The Johns Hopkins University | Dna hypermethylation of promoters of target genes and clinical diagnosis and treatment of hpv related disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19729697C1 (de) | 1997-07-11 | 1999-02-11 | Mannesmann Vdo Ag | Anordnung zum Bestimmen der relativen Luftfeuchte |
| BR9814272A (pt) * | 1997-12-12 | 2000-10-03 | Digene Corp | Meio de coleta universal |
| EP1339871B1 (de) * | 2000-08-15 | 2008-10-15 | The Johns Hopkins University School Of Medicine | Diagnose und behandlung von tumor-suppressor assoziierten krankheiten |
-
2003
- 2003-03-31 AT AT03075928T patent/ATE382099T1/de not_active IP Right Cessation
- 2003-03-31 DE DE60318294T patent/DE60318294T2/de not_active Expired - Lifetime
- 2003-03-31 ES ES03075928T patent/ES2298467T3/es not_active Expired - Lifetime
- 2003-03-31 EP EP03075928A patent/EP1464709B1/de not_active Expired - Lifetime
-
2004
- 2004-02-17 WO PCT/NL2004/000118 patent/WO2004087962A1/en active Application Filing
- 2004-02-17 US US10/551,584 patent/US7501261B2/en not_active Expired - Fee Related
-
2009
- 2009-02-11 US US12/378,077 patent/US20090203072A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60318294T2 (de) | 2008-12-11 |
| US7501261B2 (en) | 2009-03-10 |
| DE60318294D1 (de) | 2008-02-07 |
| US20090203072A1 (en) | 2009-08-13 |
| EP1464709A1 (de) | 2004-10-06 |
| EP1464709B1 (de) | 2007-12-26 |
| US20060252029A1 (en) | 2006-11-09 |
| WO2004087962A1 (en) | 2004-10-14 |
| ES2298467T3 (es) | 2008-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE382099T1 (de) | Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential | |
| Pirsaheb et al. | Current advances of carbon dots based biosensors for tumor marker detection, cancer cells analysis and bioimaging | |
| Liu et al. | Application of carbon nanoparticles in tracing lymph nodes and locating tumors in colorectal cancer: a concise review | |
| Nazarian et al. | Atypical and malignant hidradenomas: a histological and immunohistochemical study | |
| WO2008107134A3 (en) | A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene | |
| WO2006008128A3 (en) | Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders | |
| WO2006135628A3 (en) | Cytological methods for detecting a disease condition such as malignancy by raman spectroscopic imaging | |
| WO2009007958A3 (en) | Compositions, methods and kits for the diagnosis of carriers of mutations in the brca1 and brca2 genes and early diagnosis of cancerous disorders associated with mutations in brca1 and brca2 genes | |
| WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
| WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
| NZ588618A (en) | Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions | |
| Hayashi et al. | Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma | |
| WO2005072049A3 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis | |
| WO2007020522A3 (en) | Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type | |
| ATE553112T1 (de) | Ttk in der diagnose und als therapeutisches target bei krebs | |
| EA200701894A1 (ru) | Уровень транскрипции гена timp3 в качестве диагностического маркера немелкоклеточного рака легких | |
| Cocieru et al. | The role of endoscopic ultrasound and cyst fluid analysis in the initial evaluation and follow-up of incidental pancreatic cystic lesions | |
| WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal | |
| Heidari et al. | Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker | |
| ATE452339T1 (de) | Identifizierung pdgfr-alpha exprimierender nsclc (non-small cell lung carcinoma)-tumoren | |
| Takemura et al. | Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy | |
| WO2006131783A3 (en) | Polynucleotides, polypeptides, and diagnosing lung cancer | |
| WO2006021874A8 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer | |
| Badhe et al. | A study of fibroepithelial tumours of the breast | |
| van Schaik et al. | Glycoprotein Nonmetastatic Melanoma Protein B and Vascular Endothelial Growth Factor expression in head and neck cancer: potential targets for fluorescence imaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |